Nutrition in Inflammatory Bowel Disease: Strategies to Improve Prognosis and New Therapeutic Approaches DOI Creative Commons
Nallely Bueno-Hernández, Jesús K. Yamamoto‐Furusho, Viridiana Montsserrat Mendoza-Martínez

et al.

Diseases, Journal Year: 2025, Volume and Issue: 13(5), P. 139 - 139

Published: May 1, 2025

Inflammatory Bowel Disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory condition of the gastrointestinal tract that significantly impacts nutritional status. Malnutrition frequent complication, resulting from reduced nutrient intake, malabsorption, increased metabolic demands due to inflammation. A comprehensive assessment anthropometric, biochemical, dietary evaluations crucial for informing personalized interventions. Several approaches have been explored modulate inflammation gut microbiota, yielding promising results. The Mediterranean, anti-inflammatory, low-FODMAP diets shown potential benefits in symptom control. In contrast, high ultra-processed foods saturated fats are associated with worsened activity. Additionally, stool consistency, assessed using Bristol Stool Scale, serves as practical indicator adjustments, helping regulate fiber intake hydration strategies. When modifications alone insufficient, support becomes critical component IBD management. Enteral nutrition (EN) preferred whenever possible because it maintains integrity modulates immune responses. It has demonstrated efficacy reducing postoperative complications improving cases where EN not feasible, such intestinal obstruction, severe or high-output fistulas, parenteral (PN) required. choice between peripheral central administration depends on treatment duration osmolarity considerations. Despite growing evidence supporting interventions, further research needed establish standardized guidelines optimize strategies managing IBD.

Language: Английский

Nutrition in Inflammatory Bowel Disease: Strategies to Improve Prognosis and New Therapeutic Approaches DOI Creative Commons
Nallely Bueno-Hernández, Jesús K. Yamamoto‐Furusho, Viridiana Montsserrat Mendoza-Martínez

et al.

Diseases, Journal Year: 2025, Volume and Issue: 13(5), P. 139 - 139

Published: May 1, 2025

Inflammatory Bowel Disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory condition of the gastrointestinal tract that significantly impacts nutritional status. Malnutrition frequent complication, resulting from reduced nutrient intake, malabsorption, increased metabolic demands due to inflammation. A comprehensive assessment anthropometric, biochemical, dietary evaluations crucial for informing personalized interventions. Several approaches have been explored modulate inflammation gut microbiota, yielding promising results. The Mediterranean, anti-inflammatory, low-FODMAP diets shown potential benefits in symptom control. In contrast, high ultra-processed foods saturated fats are associated with worsened activity. Additionally, stool consistency, assessed using Bristol Stool Scale, serves as practical indicator adjustments, helping regulate fiber intake hydration strategies. When modifications alone insufficient, support becomes critical component IBD management. Enteral nutrition (EN) preferred whenever possible because it maintains integrity modulates immune responses. It has demonstrated efficacy reducing postoperative complications improving cases where EN not feasible, such intestinal obstruction, severe or high-output fistulas, parenteral (PN) required. choice between peripheral central administration depends on treatment duration osmolarity considerations. Despite growing evidence supporting interventions, further research needed establish standardized guidelines optimize strategies managing IBD.

Language: Английский

Citations

0